Kidney disease decisions — 2025

The appeal for service connection for residuals of prostate cancer was dismissed, while service connection was granted for diabetes mellitus and hypertension due to presumed herbicide exposure. The claim for a benign kidney tumor (claimed as kidney cancer) and an acquired psychiatric disability, including PTSD, were denied.

The Board granted service connection for hypertension, residuals of a stroke, and chronic kidney disease on a direct basis due to herbicide exposure.

The appeal regarding the timeliness of a Higher-Level Review request for service connection for renal insufficiency is dismissed as moot.

The Board denied the Veteran's claim for service connection for chronic kidney disease, finding that there was no evidence of at least 30 days of consecutive or nonconsecutive days of service at Camp Lejeune.

The Board granted service connection for tinnitus and denied service connection for hyperlipidemia, vitamin D deficiency, and other conditions. The remaining claims were remanded for further development.

The Board remands the claims for service connection for type 2 diabetes, tongue cancer, and chronic kidney condition to correct a duty to assist error.

The appeal for service connection for a penile condition and kidney stones was dismissed, while the claims for right knee, mid/lower back, and bilateral flatfoot were denied or remanded.

The Board denied a disability rating in excess of 30 percent for nephrolithiasis (kidney stones) with chronic kidney disease as the evidence did not show GFR results from 30 to 44 mL/min/1.73 m2 for at least three consecutive months during the past 12 months.

The Board denied the Veteran's claims for increased ratings and service connection for various disabilities, including radiculopathy of the lower extremities and a kidney disability.

The Board denied the veteran's claims for increased ratings for chronic renal disease and diabetic nephropathy, as well as peripheral neuropathy of the sciatic nerve in both lower extremities.

The Board granted an effective date of April 18, 2016, for service connection for kidney cancer residuals and related scars.

The Board denied an initial compensable disability rating for service-connected chronic kidney disease and remanded the claims for service connection for hydronephrosis and ureterolithiasis as secondary to the Veteran's service-connected chronic kidney disease.

The Board remands the claims for service connection for chronic liver disease cirrhosis and chronic renal disease to obtain a medical opinion addressing secondary service connection.

The Board remands the claims for a kidney condition and hysterectomy due to pre-decisional duty to assist errors, including failure to obtain relevant VA treatment records and inadequate medical opinions.

The Veteran was granted an initial 20 percent rating for her service-connected neoplasm of the kidney, status post left partial nephrectomy and denied a compensable rating for lower abdomen scars resulting from the same. The claim for service connection for frequent urination was remanded.

The Veteran's chronic kidney disease was denied a compensable rating prior to October 6, 2014, granted an 80 percent rating from October 6, 2014 to March 10, 2020, and granted a 100 percent rating from March 10, 2020 to May 21, 2022. A temporary 100 percent disability rating was granted for kidney transplant from May 22, 2022 to June 1, 2023, and a 30 percent rating was maintained after June 1, 2023.

The Board granted service connection for right and left foot disabilities but dismissed the appeal for a right kidney cyst.

The Board remands the claims for service connection for kidney stones and chronic kidney disease to obtain additional medical opinions.

The Board remands the claims for service connection for liver, testicular, renal, and neurologic disabilities due to inadequate VA examinations.

The Board denied service connection for hypertension, renal failure, and cervical cancer, as well as special monthly compensation for aid and attendance. The Board granted a disability rating of 20 percent, but no higher, prior to August 7, 2022, for chronic urinary tract infections.